Under ROC curve (Figure 2B), serum NLRC4 levels (AUC, 0.765; 95% CI, 0.685–0.846) had insignificantly lower predictive ability than NIHSS scores (AUC, 0.802; 95% CI, 0.722–0.882; P = 0.464) and hematoma volume (AUC, 0.791; 95% CI, 0.715–0.866; P = 0.590), and serum NLRC4 levels combined with NIHSS scores and hematoma volume (AUC, 0.835; 95% CI, 0.769–0.901) displayed insignificantly higher predictive capability than NIHSS scores (P = 0.125), hematoma volume (P = 0.116), and NIHSS scores combined with hematoma volume (AUC, 0.810; 95% CI, 0.734–0.885; P = 0.170). This evidence concerns the gene NLRC4 and hematoma.